✦ LIBER ✦

Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma

✍ Scribed by William F. Cassano; John Graham-Pole; Nancy Dickson

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 349 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19911101)68:9<1899::aid-cncr2820680909>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, doxorubicin, cyclophosphamide

Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer

✍ Joseph Aisner; Margaret Y. Whitacre; Daniel R. Budman; Kathy Propert; Gary Strau 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 442 KB

Response of osteogenic sarcoma to the co

Response of osteogenic sarcoma to the combination of etoposide and cyclophosphamide as neoadjuvant chemotherapy

✍ Ramy A. Saleh; John Graham-Pole; William Cassano; Frank Abbot; Robert Vander Gri 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB 👁 2 views

Pilot study of cyclophosphamide-doxorubi

Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer

✍ Taisuke Ohnoshi; Shunkichi Hiraki; Hiroshi Ueoka; Katsuyuki Kiura; Haruhito Kame 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

Cyclophosphamide, doxorubicin, and cispl

Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin

✍ Arnon I. Dreyfuss; John R. Clark; Barbara G. Fallon; Marshall R. Posner; Charles 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 2 views

Thirteen patients with carcinomas of major and minor salivary gland origin (nine adenoid cystic carcinomas and four adenocarcinomas) were treated with cyclophosphamide (500 mg/m2), doxorubicin (50 mg/m2), and cisplatin (50 mg/m2) (CAP) by intravenous injections on the first day of a 28-day regimen.

Weekly doxorubicin versus doxorubicin ev

Weekly doxorubicin versus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer

✍ Theera Umsawasdi; Manuel Valdivieso; Daniel J. Booser; H. Thomas Barkley Jr; Mic 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Weekly chemotherapy with cisplatin, vinc

Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma

✍ Kiyotaka Yoh; Koichi Goto; Gen-ichiro Ishii; Seiji Niho; Hironobu Ohmatsu; Kaoru 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract ## BACKGROUND Thymic carcinoma is a rare neoplasm that often disseminates or metastasizes. The role of chemotherapy in treating this malignancy is unclear. The purpose of the current study was to determine the efficacy and tolerability of a weekly chemotherapy regimen consisting of cis